- Home
- CATX vs AXIN Comparison
CATX vs AXIN Comparison
Compare CATX & AXIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CATX
- AXIN
- Stock Information
- Founded
- CATX 1983
- AXIN 2025
- Country
- CATX United States
- AXIN United Kingdom
- Employees
- CATX N/A
- AXIN N/A
- Industry
- CATX Medical/Dental Instruments
- AXIN
- Sector
- CATX Health Care
- AXIN
- Exchange
- CATX Nasdaq
- AXIN Nasdaq
- Market Cap
- CATX 239.0M
- AXIN 272.1M
- IPO Year
- CATX N/A
- AXIN 2025
- Fundamental
- Price
- CATX $3.87
- AXIN $9.97
- Analyst Decision
- CATX Strong Buy
- AXIN
- Analyst Count
- CATX 10
- AXIN 0
- Target Price
- CATX $12.90
- AXIN N/A
- AVG Volume (30 Days)
- CATX 835.6K
- AXIN 28.8K
- Earning Date
- CATX 11-11-2025
- AXIN 01-01-0001
- Dividend Yield
- CATX N/A
- AXIN N/A
- EPS Growth
- CATX N/A
- AXIN N/A
- EPS
- CATX N/A
- AXIN N/A
- Revenue
- CATX $1,235,000.00
- AXIN N/A
- Revenue This Year
- CATX N/A
- AXIN N/A
- Revenue Next Year
- CATX N/A
- AXIN N/A
- P/E Ratio
- CATX N/A
- AXIN N/A
- Revenue Growth
- CATX N/A
- AXIN N/A
- 52 Week Low
- CATX $1.60
- AXIN $9.93
- 52 Week High
- CATX $13.44
- AXIN $9.98
- Technical
- Relative Strength Index (RSI)
- CATX 53.74
- AXIN N/A
- Support Level
- CATX $3.37
- AXIN N/A
- Resistance Level
- CATX $3.78
- AXIN N/A
- Average True Range (ATR)
- CATX 0.20
- AXIN 0.00
- MACD
- CATX 0.04
- AXIN 0.00
- Stochastic Oscillator
- CATX 66.14
- AXIN 0.00
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
About AXIN Axiom Intelligence Acquisition Corp 1 Class A Ordinary Shares
Axiom Intelligence Acquisition Corp 1 is a blank check company.